175 related articles for article (PubMed ID: 28666825)
1. Triptonide acts as a novel potent anti-lymphoma agent with low toxicity mainly through inhibition of proto-oncogene Lyn transcription and suppression of Lyn signal pathway.
Yang P; Dong F; Zhou Q
Toxicol Lett; 2017 Aug; 278():9-17. PubMed ID: 28666825
[TBL] [Abstract][Full Text] [Related]
2. Targeting of multiple senescence-promoting genes and signaling pathways by triptonide induces complete senescence of acute myeloid leukemia cells.
Pan Y; Meng M; Zheng N; Cao Z; Yang P; Xi X; Zhou Q
Biochem Pharmacol; 2017 Feb; 126():34-50. PubMed ID: 27908660
[TBL] [Abstract][Full Text] [Related]
3. Triptonide inhibits lung cancer cell tumorigenicity by selectively attenuating the Shh-Gli1 signaling pathway.
Zhang M; Tan S; Yu D; Zhao Z; Zhang B; Zhang P; Lv C; Zhou Q; Cao Z
Toxicol Appl Pharmacol; 2019 Feb; 365():1-8. PubMed ID: 30610878
[TBL] [Abstract][Full Text] [Related]
4. Triptonide effectively suppresses gastric tumor growth and metastasis through inhibition of the oncogenic Notch1 and NF-κB signaling pathways.
Xiang S; Zhao Z; Zhang T; Zhang B; Meng M; Cao Z; Zhou Q
Toxicol Appl Pharmacol; 2020 Feb; 388():114870. PubMed ID: 31866380
[TBL] [Abstract][Full Text] [Related]
5. Oroxin B selectively induces tumor-suppressive ER stress and concurrently inhibits tumor-adaptive ER stress in B-lymphoma cells for effective anti-lymphoma therapy.
Yang P; Fu S; Cao Z; Liao H; Huo Z; Pan Y; Zhang G; Gao A; Zhou Q
Toxicol Appl Pharmacol; 2015 Oct; 288(2):269-79. PubMed ID: 26253462
[TBL] [Abstract][Full Text] [Related]
6. Triptonide acts as a novel antiprostate cancer agent mainly through inhibition of mTOR signaling pathway.
Dong F; Yang P; Wang R; Sun W; Zhang Y; Wang A; Chen M; Chen L; Zhang C; Jiang M
Prostate; 2019 Aug; 79(11):1284-1293. PubMed ID: 31212374
[TBL] [Abstract][Full Text] [Related]
7. Eriocalyxin B induces apoptosis in lymphoma cells through multiple cellular signaling pathways.
Zhang YW; Jiang XX; Chen QS; Shi WY; Wang L; Sun HD; Shen ZX; Chen Z; Chen SJ; Zhao WL
Exp Hematol; 2010 Mar; 38(3):191-201. PubMed ID: 20045442
[TBL] [Abstract][Full Text] [Related]
8. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.
Blaskovich MA; Sun J; Cantor A; Turkson J; Jove R; Sebti SM
Cancer Res; 2003 Mar; 63(6):1270-9. PubMed ID: 12649187
[TBL] [Abstract][Full Text] [Related]
9. [Effect of sodium aescinate in inducing human breast cancer MCF-7 cells apoptosis by inhibiting AKT, ERK and upstream signal SRC activity].
Qi SM; Lv J; Meng Y; Qi ZL; Ling LF
Zhongguo Zhong Yao Za Zhi; 2015 Aug; 40(16):3267-72. PubMed ID: 26790305
[TBL] [Abstract][Full Text] [Related]
10. Identification of triptonide as a therapeutic agent for triple negative breast cancer treatment.
Gao B; Chen J; Han B; Zhang X; Hao J; Giuliano AE; Cui Y; Cui X
Sci Rep; 2021 Jan; 11(1):2408. PubMed ID: 33510281
[TBL] [Abstract][Full Text] [Related]
11. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
12. Selective activation of tumor-suppressive MAPKP signaling pathway by triptonide effectively inhibits pancreatic cancer cell tumorigenicity and tumor growth.
Zhang B; Meng M; Xiang S; Cao Z; Xu X; Zhao Z; Zhang T; Chen B; Yang P; Li Y; Zhou Q
Biochem Pharmacol; 2019 Aug; 166():70-81. PubMed ID: 31075266
[TBL] [Abstract][Full Text] [Related]
13. R115777 (Zarnestra)/Zoledronic acid (Zometa) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation.
Caraglia M; Marra M; Leonetti C; Meo G; D'Alessandro AM; Baldi A; Santini D; Tonini G; Bertieri R; Zupi G; Budillon A; Abbruzzese A
J Cell Physiol; 2007 May; 211(2):533-43. PubMed ID: 17192846
[TBL] [Abstract][Full Text] [Related]
14. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway.
Siwak DR; Shishodia S; Aggarwal BB; Kurzrock R
Cancer; 2005 Aug; 104(4):879-90. PubMed ID: 16007726
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A
Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504
[TBL] [Abstract][Full Text] [Related]
16. Quinacrine induces apoptosis in human leukemia K562 cells via p38 MAPK-elicited BCL2 down-regulation and suppression of ERK/c-Jun-mediated BCL2L1 expression.
Changchien JJ; Chen YJ; Huang CH; Cheng TL; Lin SR; Chang LS
Toxicol Appl Pharmacol; 2015 Apr; 284(1):33-41. PubMed ID: 25684043
[TBL] [Abstract][Full Text] [Related]
17. DCZ3301, a novel cytotoxic agent, inhibits proliferation in diffuse large B-cell lymphoma via the STAT3 pathway.
Sun X; Li B; Xie B; Xu Z; Chang G; Tao Y; Zhang Y; Chang S; Wang Y; Yu D; Xie Y; Li T; Wang H; Chen G; Hu L; Hou J; Zhang Y; Xiao W; Gao L; Shi J; Zhu W
Cell Death Dis; 2017 Oct; 8(10):e3111. PubMed ID: 29022919
[TBL] [Abstract][Full Text] [Related]
18. PKCε inhibits isolation and stemness of side population cells via the suppression of ABCB1 transporter and PI3K/Akt, MAPK/ERK signaling in renal cell carcinoma cell line 769P.
Huang B; Fu SJ; Fan WZ; Wang ZH; Chen ZB; Guo SJ; Chen JX; Qiu SP
Cancer Lett; 2016 Jun; 376(1):148-54. PubMed ID: 27037060
[TBL] [Abstract][Full Text] [Related]
19. Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity.
Sun J; Blaskovich MA; Jove R; Livingston SK; Coppola D; Sebti SM
Oncogene; 2005 May; 24(20):3236-45. PubMed ID: 15735720
[TBL] [Abstract][Full Text] [Related]
20. Activation of the tumor suppressive Hippo pathway by triptonide as a new strategy to potently inhibit aggressive melanoma cell metastasis.
Tan S; Zhao Z; Qiao Y; Zhang B; Zhang T; Zhang M; Qi J; Wang X; Meng M; Zhou Q
Biochem Pharmacol; 2021 Mar; 185():114423. PubMed ID: 33476574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
